Results 121 to 130 of about 25,820 (298)

HYPOPARATHYROIDISM: MODERN CONCEPTS AND ANALYSIS OF A CLINICAL CASE

Архивъ внутренней медицины, 2016
The article deals with modern concepts of etiopathogenesis, clinic, diagnosis and treatment of hypoparathyroidism. Pathophysiological mechanisms of clinical symptoms are described. The paper contains the analyzis of autoimmune hypoparathyroidism clinical
L. M. Farkhutdinova, M. A. Ivanova, V. F. Tunik   +2 more
doaj   +1 more source

Effects of oral activated charcoal on hyperphosphatemia and vascular calcification in Chinese patients with stage 3–4 chronic kidney disease

JN. Journal of Nephrology (Milano. 1992), 2018
BackgroundThe relationship between oral activated charcoal (OAC) and hyperphosphatemia and vascular calcification is not completely clear. We observed and recorded the effects of OAC on hyperphosphatemia and vascular calcification in stage 3–4 chronic ...
Ying Gao, Guiyun Wang, Yang Li, Chenxiao Lv, Zunsong Wang   +4 more
semanticscholar   +1 more source

Conditional Deletion of Murine Fgf23: Interruption of the Normal Skeletal Responses to Phosphate Challenge and Rescue of Genetic Hypophosphatemia [PDF]

, 2016
The transgenic and knockout (KO) animals involving Fgf23 have been highly informative in defining novel aspects of mineral metabolism, but are limited by shortened lifespan, inability of spatial/temporal FGF23 control, and infertility of the global KO ...
Allen, Matthew R., Bellido, Teresita, Cass, Taryn A., Clinkenbeard, Erica L., Hum, Julia M., Ni, Pu, White, Kenneth E.   +6 more
core   +1 more source

Recessive mutation in GALNT3 causes hyperphosphatemic familial tumoral calcinosis associated with chronic recurrent multifocal osteomyelitis

The Turkish Journal of Pediatrics, 2019
Hyperphosphatemic familial tumoral calcinosis is a rare autosomal recessive disorder that is characterized by persistent hyperphosphatemia and extra-articular calcifications.
Jumana Albaramki, Haitham Dmour, Mohammad Shboul, Carine Bonnard, Byrappa Venkatesh, Rasha Odeh   +5 more
doaj   +1 more source

EXPERIENCE OF LONG-TERM TERIPARATIDE USE FOR THE TREATMENT OF POSTOPERATIVE HYPOPARATHYROIDISM ASSOCIATED WITH OSTEOPOROSIS IN ELDERLY PATIENT

Klinicist, 2018
The aim of study is to reflect the possibilities and effectiveness of teriparatide for the treatment of postoperative hypoparathyroidism associated with severe systemic osteoporosis, based on the data of the clinical case.Materials and methods. Patient N.
G. A. Batrak, A. N. Brodovskaya, S. E. Myasoedova   +2 more
doaj   +1 more source

Cost effectiveness of lanthanum carbonate in chronic kidney disease patients in Spain before and during dialysis [PDF]

, 2015
AIMS: In Spain, the first line treatment of hyperphosphatemia in Chronic Kidney Disease (CKD) consists of calciumbased phosphate binders (CB). However, their use is associated with vascular calcification and an increased mortality risk.
Antonio Galán, Blanca Gros, Emilio González-Parra, Itziar Oyagüez, Jose A Herrero, Keith Tolley, Maria Echave, Stefan Vegter   +7 more
core   +1 more source

Effectiveness and safety of a 6-month treatment with paricalcitol in patients on hemodialysis with secondary hyperparathyroidism

Brazilian Journal of Nephrology
Introduction: The mineral bone disorder, particularly secondary hyperparathyroidism, in chronic kidney disease (CKD) has a systemic impact affecting not only bone metabolism.
Inés Olaizola, Hena Caorsi, Laura Fajardo, Alejandro Ferreiro, Nieves Campistrus, Deyanira Dolinsky, Alicia Petraglia, Pablo Ambrosoni   +7 more
doaj   +1 more source

Hyperphosphatemia induces senescence in human endothelial cells by increasing endothelin‐1 production

Aging Cell, 2017
Hyperphosphatemia is related to some pathologies, affecting vascular cell behavior. This work analyzes whether high concentration of extracellular phosphate induces endothelial senescence through up‐regulation of endothelin‐1 (ET‐1), exploring the ...
G. Olmos, P. Martínez-Miguel, Elena Alcalde-Estévez, Diana R. Medrano, Patricia Sosa, L. Rodríguez-Mañas, M. Naves-Diaz, D. Rodríguez‐Puyol, M. Ruíz-Torres, S. López-Ongil   +9 more
semanticscholar   +1 more source

Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: A comparison with calcium acetate [PDF]

, 2003
Treatment of hyperphosphatemia with sevelamer hydrochloride in hemodialysis patients: A comparison with calcium acetate.BackgroundSevelamer hydrochloride is a recently approved calcium- and aluminium-free phosphate binder.
Cerezo, Sebastián, Hervás, José G., Prados, Dolores   +2 more
core   +1 more source

New Developments in Hyperphosphatemia Management [PDF]

Journal of the American Society of Nephrology, 2003
Patients with chronic renal failure have many associated medical problems, including a high propensity for cardiovascular disease (CVD). CVD and stroke are the leading causes of mortality in patients with ESRD (chronic kidney disease stage 5), with a 10- to 20-fold greater risk than in the general population (1,2).
openaire   +2 more sources